Skip to main content
. 2019 Aug 15;30(18):2349–2357. doi: 10.1091/mbc.E19-03-0159

TABLE 1:

Primary antibodies.

Antibody and source Dilution
Rtn4a/Nogo-A; Abcam (ab62024) IF, 1:50; WB, 1:500
Integrin β1; Invitrogen (PA5-29606; for HeLa) IF, 1:100
Integrin β1; Bethyl Laboratories (A303-735A; for HeLa) WB, 1:1000
Integrin β1; Santa Cruz Biotechnology (sc-53711; for Neuro-2a) IF, 1:50; WB, 1:200
Climp63/CKAP4; Invitrogen (PA5-42926) IF, 1:100
HLA-A; Santa Cruz Biotechnology (sc-390473) IF, 1:60; WB, 1:200
KDEL; Santa Cruz Biotechnology (sc-58774) WB, 1:1000
β-actin (rabbit); RevMAb Biosciences (31-1013-00) WB, 1:1000
β-actin (mouse); Abcam (ab8224) WB, 1:1000
ERp72; ProSci (8211) WB, 1:1000
GRP78; Assay Biotech (C0217) WB, 1:500
REEP5; Abcam (ab76451) IF, 1:100
Rtn4/Nogo; Santa Cruz Biotechnology (sc-271878) IF, 1:75
Rtn4; Aviva Systems Biology (ARP46812_P050) WB, 1:500